Signet Financial Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Signet Financial Management, LLC

$778 Million
Q3 2024

A detailed history of Signet Financial Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Signet Financial Management, LLC holds 4,030 shares of REGN stock, worth $2.83 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

4,030

Previous 4,025 0.12%

Holding current value

$2.83 Million

Previous $4.23 Million 0.14%

% of portfolio

0.54%

Previous 0.58%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$1024.09 - $1201.76 $5,120 - $6,008	5 Added 0.12%	4,030 $4.24 Million
Q2 2024 Aug 02, 2024	BUY	$883.2 - $1071.19 $4,416 - $5,355	5 Added 0.12%	4,025 $4.23 Million
Q1 2024 Apr 15, 2024	BUY	$902.69 - $993.35 $70,409 - $77,481	78 Added 1.98%	4,020 $3.87 Million
Q4 2023 Jan 30, 2024	SELL	$775.18 - $881.7 $775 - $881	-1 Reduced 0.03%	3,942 $3.46 Million
Q3 2023 Oct 25, 2023	SELL	$692.45 - $844.37 $31,852 - $38,841	-46 Reduced 1.15%	3,943 $3.24 Million
Q2 2023 Jul 18, 2023	BUY	$700.03 - $830.35 $16,800 - $19,928	24 Added 0.61%	3,989 $2.87 Million
Q1 2023 Apr 17, 2023	BUY	$680.49 - $826.97 $7,485 - $9,096	11 Added 0.28%	3,965 $3.26 Million
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $23,294 - $25,290	-33 Reduced 0.83%	3,954 $2.85 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $11,479 - $14,486	20 Added 0.5%	3,987 $2.75 Million
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $30,351 - $35,619	51 Added 1.3%	3,967 $2.77 Million
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $22,826 - $28,180	42 Added 1.08%	3,916 $2.47 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $6,314 - $7,490	11 Added 0.28%	3,874 $2.35 Million
Q2 2021 Aug 09, 2021	SELL	$472.8 - $558.54 $1,891 - $2,234	-4 Reduced 0.1%	3,863 $2.16 Million
Q1 2021 May 05, 2021	SELL	$446.73 - $548.2 $57,628 - $70,717	-129 Reduced 3.23%	3,867 $1.83 Million
Q4 2020 Feb 10, 2021	SELL	$478.3 - $607.98 $51,178 - $65,053	-107 Reduced 2.61%	3,996 $1.93 Million
Q3 2020 Nov 05, 2020	SELL	$544.75 - $658.21 $108,950 - $131,642	-200 Reduced 4.65%	4,103 $2.41 Million
Q2 2020 Aug 18, 2020	SELL	$493.32 - $643.92 $244,193 - $318,740	-495 Reduced 10.32%	4,303 $2.62 Million
Q1 2020 May 20, 2020	SELL	$336.18 - $494.43 $203,388 - $299,130	-605 Reduced 11.2%	4,798 $2.68 Million
Q4 2019 Jan 23, 2020	SELL	$274.13 - $376.51 $30,976 - $42,545	-113 Reduced 2.05%	5,403 $2.03 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $97,078 - $113,028	-355 Reduced 6.05%	5,516 $1.9 Million
Q2 2019 Aug 13, 2019	SELL	$299.6 - $414.82 $235,186 - $325,633	-785 Reduced 11.79%	5,871 $1.82 Million
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $92,275 - $109,013	-248 Reduced 3.59%	6,656 $2.23 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $2.17 Million - $2.61 Million	6,475 Added 1509.32%	6,904 $2.58 Million
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $9,831 - $11,438	28 Added 6.98%	429 $173,000
Q2 2018 Aug 10, 2018	BUY	$284.6 - $344.99 $114,124 - $138,340	401 New	401 $138,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signet Financial Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signet Financial Management, LLC with notifications on news.

Account

Signet Financial Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History